Literature DB >> 20085742

Characterization of trisulfide modification in antibodies.

Sheng Gu1, Dingyi Wen, Paul H Weinreb, Yaping Sun, Lihe Zhang, Susan F Foley, Rashmi Kshirsagar, David Evans, Sha Mi, Werner Meier, R Blake Pepinsky.   

Abstract

Trisulfides are a posttranslational modification formed by the insertion of a sulfur atom into a disulfide bond. Although reports for trisulfides in proteins are limited, we find that they are a common modification in natural and recombinant antibodies of all immunoglobulin G (IgG) subtypes. Trisulfides were detected only in interchain linkages and were predominantly in the light-heavy linkages. Factors that lead to trisulfide formation and elimination and their impact on activity and stability were investigated. The peptide mapping methods developed for characterization and quantification of trisulfides should be applicable to any antibody and can be easily adapted for other types of proteins. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20085742     DOI: 10.1016/j.ab.2010.01.019

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  27 in total

1.  Characterization and comparison of disulfide linkages and scrambling patterns in therapeutic monoclonal antibodies: using LC-MS with electron transfer dissociation.

Authors:  Yi Wang; Qiaozhen Lu; Shiaw-Lin Wu; Barry L Karger; William S Hancock
Journal:  Anal Chem       Date:  2011-03-23       Impact factor: 6.986

Review 2.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

3.  Simplified identification of disulfide, trisulfide, and thioether pairs with 213 nm UVPD.

Authors:  James Bonner; Lance E Talbert; Nicholas Akkawi; Ryan R Julian
Journal:  Analyst       Date:  2018-10-22       Impact factor: 4.616

Review 4.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Guanbo Wang; Burcu Baykal; Shunhai Wang
Journal:  Biotechnol Adv       Date:  2011-05-17       Impact factor: 14.227

Review 5.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

Review 6.  In Vivo Stability of Therapeutic Proteins.

Authors:  Joachim Schuster; Atanas Koulov; Hanns-Christian Mahler; Pascal Detampel; Joerg Huwyler; Satish Singh; Roman Mathaes
Journal:  Pharm Res       Date:  2020-01-03       Impact factor: 4.200

7.  The impact of trisulfide modification of antibodies on the properties of antibody-drug conjugates manufactured using thiol chemistry.

Authors:  Renpeng Liu; Xuan Chen; Junia Dushime; Megan Bogalhas; Alexandru C Lazar; Thomas Ryll; Lintao Wang
Journal:  MAbs       Date:  2017-01-31       Impact factor: 5.857

8.  IgG1 thioether bond formation in vivo.

Authors:  Qingchun Zhang; Matthew R Schenauer; John D McCarter; Gregory C Flynn
Journal:  J Biol Chem       Date:  2013-04-25       Impact factor: 5.157

9.  Impact of S-sulfocysteine on fragments and trisulfide bond linkages in monoclonal antibodies.

Authors:  Ronja Seibel; Sandra Maier; Alisa Schnellbaecher; Susanne Bohl; Maria Wehsling; Anne Zeck; Aline Zimmer
Journal:  MAbs       Date:  2017-06-05       Impact factor: 5.857

10.  Thiol-disulfide exchange in peptides derived from human growth hormone.

Authors:  Saradha Chandrasekhar; Daniel E Epling; Andreas M Sophocleous; Elizabeth M Topp
Journal:  J Pharm Sci       Date:  2014-02-18       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.